1. Khanshour, Anas M, Kidane, Yared H, Kozlitina, Julia, Gurnett, Christina A, Rios, Jonathan J. . Genetic association and characterization of FSTL5 in isolated clubfoot. In Human molecular genetics, 29, 3717-3728. doi:10.1093/hmg/ddaa236. https://pubmed.ncbi.nlm.nih.gov/33105483/
2. Li, Chunlei, Dai, Lei, Zhang, Junfeng, Wei, Yuquan, Deng, Hongxin. 2018. Follistatin-like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase-dependent apoptosis and regulating Bcl-2 family proteins. In Journal of cellular and molecular medicine, 22, 6190-6201. doi:10.1111/jcmm.13906. https://pubmed.ncbi.nlm.nih.gov/30255547/
3. Zhang, Deng-Yong, Lei, Jia-Sheng, Sun, Wan-Liang, Wang, Dong-Dong, Lu, Zheng. . Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma. In Chinese medical journal, 133, 1798-1804. doi:10.1097/CM9.0000000000000847. https://pubmed.ncbi.nlm.nih.gov/32740091/
4. Zhang, Deng-Yong, Sun, Wan-Liang, Ma, Xiang, Zhou, Shuo, Lu, Zheng. 2017. Up-regulated FSTL5 inhibits invasion of hepatocellular carcinoma through the Wnt/β-catenin/YAP pathway. In International journal of clinical and experimental pathology, 10, 10325-10333. doi:. https://pubmed.ncbi.nlm.nih.gov/31966367/
5. Remke, Marc, Hielscher, Thomas, Korshunov, Andrey, Lichter, Peter, Pfister, Stefan M. 2011. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. In Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29, 3852-61. doi:10.1200/JCO.2011.36.2798. https://pubmed.ncbi.nlm.nih.gov/21911727/
6. Jang, Yura, Oh, Sungtaek, Hall, Anna J, Na, Chan Hyun, Pantelyat, Alexander Y. 2024. Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid. In Clinical proteomics, 21, 56. doi:10.1186/s12014-024-09507-3. https://pubmed.ncbi.nlm.nih.gov/39342078/
智鼠故事 
